share_log

Earnings Call Summary | Core Laboratories(CLB.US) Q1 2024 Earnings Conference

Earnings Call Summary | Core Laboratories(CLB.US) Q1 2024 Earnings Conference

業績電話會議摘要 | 核心實驗室 (CLB.US) 2024 年第一季度業績會議
富途資訊 ·  04/26 01:57  · 電話會議

The following is a summary of the Core Laboratories Inc. (CLB) Q1 2024 Earnings Call Transcript:

以下是核心實驗室公司(CLB)2024年第一季度業績電話會議記錄的摘要:

Financial Performance:

財務業績:

  • Core Laboratories Inc. reported Q1 2024 revenue of $129.6 million, slightly up from the previous quarter's $128.2 million.

  • Despite a seasonal decline, the company managed a 1% increase in revenue compared to Q4 2023.

  • Operating income for Q1 was $14.9 million, maintaining the same operating margins of 12%.

  • Despite an 11% decrease in U.S. land-based activities, Core's U.S. completion diagnostic services and product sales rose sequentially.

  • Improvement noted in Production Enhancement revenue, operating income and operating margins, latter rising from 6% in Q4 to 8% in Q1.

  • Core reduced Q1 debt by $3 million post-dividend payout.

  • Earnings per share in Q1 remained flat at $0.19, the same as Q4 2023.

  • Total long-term debt at the end of Q1 was estimated at $163 million with a net debt of $148.1 million.

  • Free Cash Flow during Q1 was $2.5 million, primarily utilized for debt reduction.

  • 核心實驗室公司公佈的2024年第一季度收入爲1.296億美元,略高於上一季度的1.282億美元。

  • 儘管出現季節性下降,但與2023年第四季度相比,該公司的收入增長了1%。

  • 第一季度的營業收入爲1,490萬美元,保持了12%的相同營業利潤率。

  • 儘管美國陸上活動下降了11%,但Core在美國的完工診斷服務和產品銷售額環比增長。

  • 產量增強收入、營業收入和營業利潤率有所改善,後者從第四季度的6%上升到第一季度的8%。

  • Core在分紅後派息後將第一季度的債務減少了300萬美元。

  • 第一季度的每股收益持平至0.19美元,與2023年第四季度相同。

  • 第一季度末的長期債務總額估計爲1.63億美元,淨負債爲1.481億美元。

  • 第一季度自由現金流爲250萬美元,主要用於債務減免。

Business Progress:

業務進展:

  • Despite decreasing U.S. land completion activity, Core's U.S. completion diagnostic services saw an increase, especially in the evaluation of complex completion designs.

  • Despite transport disruptions in the Middle East and conflicts in Ukraine-Russia, demand for rock and fluid analysis remains strong across global client base.

  • Core Labs plans to introduce new product and service offerings in key markets.

  • Their carbon capture and sequestration consortium held its second meeting, focusing on CO2 exposure's effects on rock types with future focus on upscaling lab results to reservoir level.

  • Core Labs extended its downhole Metal Anomaly Tool technology to implement on high chromium content casing.

  • Core views 2024 as a year of improved activity levels and new market penetration, with projected crude oil demand at a record high.

  • Revenue predictions for Q2 2024 are between $130 million and $136 million with operating income between $14.5 and $17.3 million and EPS between $0.19 and $0.23.

  • Company acknowledges reduced cash generation, with profitability hinging on increased activity levels. Despite issues like longer invoice collection periods and overcrowding in the completion products segment, it is optimistic about its technological capabilities and improving global landscape.

  • 儘管美國的土地完工活動有所減少,但Core的美國完工診斷服務仍有所增加,尤其是在複雜完工設計的評估方面。

  • 儘管中東交通中斷,烏克蘭-俄羅斯也發生了衝突,但全球客戶群對岩石和流體分析的需求仍然強勁。

  • Core Labs計劃在關鍵市場推出新的產品和服務。

  • 他們的碳捕集與封存聯盟舉行了第二次會議,重點討論二氧化碳暴露對岩石類型的影響,未來的重點是將實驗室結果擴大到儲層水平。

  • Core Labs 擴展了其井下金屬異常工具技術,使其可在高鉻含量的外殼上實現。

  • Core將2024年視爲活動水平提高和新市場滲透率的一年,預計原油需求將創歷史新高。

  • 2024年第二季度的收入預測在1.3億美元至1.36億美元之間,營業收入在1450萬美元至1730萬美元之間,每股收益在0.19美元至0.23美元之間。

  • 公司承認現金產生減少,盈利能力取決於活動水平的增加。儘管存在諸如發票收取期更長和完工產品領域人滿爲患等問題,但它對其技術能力和全球格局的改善持樂觀態度。

More details: Core Laboratories IR

更多詳情: 核心實驗室 IR

Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.

提示:欲了解更多詳情,請訪問投資者關係網站。本文僅供投資者參考,不構成任何投資建議。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論